Welcome to Plantfeed Shop!


0.
Cart is empty.


Call Now!


Secure Site

100% secure site

Free Shipping

on orders over $100

More Views


Quick Overview

ADB-FUBINACA features a carboxamide group at the 3-indazole position, like SDB-001 and STS-135. ADB-FUBINACA appears to be the product of rational drug design, since it differs from AB-FUBINACA only by the replacement of the isopropyl group with a tert-butyl group. AB-FUBINACA is a synthetic compound and falls under cannabinoids class. Members of this group are known to produce cannabis-like effects. AB-FUBINACA was originally developed by Pfizer in 2009 as an analgesic medication but was not pursued for human use. Although this substance has not been formally studied, it is presumed that AB-FUBINACA has a similar profile to that of other cannabinoids and matches many of the in vivo properties of Δ9-THC. AB-FUBINACA exhibits its range of effects via full agonism of both the CB1 and CB2 cannabinoid receptors, with some selectivity for CB2. Primary effect of this chemical on a user is sedating, which discourages physical activities like running, jumping, etc. Consumption of this chemical causes an increase in appetite, other effects include dehydration, dry mouth and nausea.

Availability: In stock

Only 984 left

Formal Name :
CAS Number :
1445583-51-6 Yes
Molecular Formula :
Purity :
Molecular Weight :

Delivery Time 7-14 days

* Required Fields